COVID-19 Vaccination Preparedness

Delivering a path out of the crisis together

BD has mobilized and our devices are set to deliver the COVID-19 vaccine to the world

In the midst of this global pandemic, we understand the responsibility we carry as the world’s largest manufacturer of injection devices. This position of leadership is why we responded to the crisis early—rapidly scaling up our manufacturing operations. We’re here now, delivering a path out of this crisis, so we can enable healthcare providers to deliver the best possible patient care, which includes meeting the critical need for vaccinations.

View BD Statement on U.S. Needle and Syringe Availability

BD has already committed 2 billion injection devices to countries and nongovernmental organizations around the world*

* Publicly confirmed as of June 2021

The journey of a vaccine delivery device

Ordered

Produced

Inspected

Distributed

BD is working with governments and organizations around the world to produce and supply injection devices for COVID-19 vaccination campaigns.

As orders get placed, BD business and operations teams carefully plan new demand to not disrupt routine patient care.

Manufacturing and packaging of needles and syringes

Plastic pellets called resin are heated, melted and injected into molds to create the syringe and plastic needle parts. Stainless steel strip is rolled into a tube, welded and shrunk to the proper wall thickness and gauge. This cannula is cut to length and put through a grinding process to form the sharp needle point. Separately, the parts for the needle and syringe are fed into high-speed assembly machines and then packaged.

We’re doubling down on what we do best—accessing our vast experience to help solve the healthcare community’s biggest challenges, working with urgency, as we innovate and ensure our front lines have the innovative solutions and tools they need to address this pandemic and enhance patient care, as they impact lives around the world.

—

Tom Polen, Chairman, CEO and President

Committed to enabling healthcare providers to deliver the best possible care. View our infographic to see how.

View infographic

BD has been by the side of vaccine developers and healthcare providers for decades, ensuring the availability and safe administration of vaccines from polio to the seasonal flu.

BD is partnering with governments and NGOs to ensure we deliver the right type of injection device in the right quantities to the right place at the right time.

BD has accelerated production of needles and syringes to ensure continuity of supply to our customers, while prioritizing patient care and meeting the requests for heightened vaccination needs.

** This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA for use by authorized laboratories.

This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

BD-22503 (06/21)